Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer
✍ Scribed by Kirsimari Aaltonen; Rose-Marie Amini; Göran Landberg; Hannaleena Eerola; Kristiina Aittomäki; Päivi Heikkilä; Heli Nevanlinna; Carl Blomqvist
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 194 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To better understand the molecular basis for the hormoneresponsive phenotype in breast cancer, we have used a human cDNA array to compare patterns of gene expression between breast carcinoma cell lines discordant for estrogen receptor (ER) expression. These experiments indicated abundant expression
## Abstract Mutations in DNA double‐strand breaks (DSB) repair genes are involved in the pathogenesis of hereditary mammary tumors, it is, however, still unclear whether defects in this pathway may play a role in sporadic breast cancer. In this study, we initially determined mRNA expression of 15 D
Background and Objectives: p27Kip1 is an inhibitor of cyclindependent kinases and is speculated to be a potential prognostic indicator in numerous human cancers. We investigated expression of p27Kip1 along with cyclin D1 in gastric cancer to estimate the clinical utility of p27Kip1. Methods: Immunoh